The global market for scleral lenses is expected to enjoy a valuation of US$ 175.5 million in the year 2022, and further expand at a CAGR of 6.3% to reach a valuation of ~US$ 323.5 million by the year 2032. According to a recent study by Future Market Insights, the mini scleral lenses in the product segment are leading the market with a share of about 47.4% in the year 2021, within the global market.
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | US$ 175.5 million |
| Market Value 2032 | US$ 323.5 million |
| CAGR 2022 to 2032 | 6.3% |
| Market Share of Top 5 Countries | 73.3% |
| Key Market Players | Cooper Vision, (VisionaryOptic) Euclid Systems, Bausch & Lomb, Art Optical Contact Lens, Inc., AccuLens, Valley Contax Inc., ABB Optical Group, EssilorLuxottica, Optact International Ltd., Solotica, Smart Optics LLC, OPTO CENTAR, OKVision, No7 Contact Lenses, Multilens AB, Laboratoire LCS, HERZ submicron lathing s.r.l., Gelflex, Firma Concor Ltd., Biolens Lab, Appenzeller Kontaktlinsen AG, Advanced Vision Technologies, and Metro Optics |
Scleral lenses are large-diameter lenses that have been specifically designed to completely cover the sclera and corneal surface. Scleral lenses are more stable on the eyes than other conventional lenses because of their size. These lenses are highly breathable and are made of stiff permeable lens materials wherein the surface of the eyes receives plenty of oxygen because of the high-quality material properties of these lenses.
Scleral lenses are used for conditions like corneal irregularity, surface ocular disease, and refractive error. It is used to treat a variety of diseases, including keratoconus, microphthalmia, neurotrophic keratitis, dry eye syndrome, pellucid marginal degeneration, corneal scarring, and other ailments.
Manufacturers offer scleral lenses that are specifically sized and diseased to meet the needs of patients. Scleral lenses are becoming a popular treatment option for older people and youngsters. People whose eyes are too sensitive for smaller contact lenses are increasingly turning to scleral lenses.
Thus owing to such importance and advancement in the product portfolio, the global scleral lenses market is expected to see growth in the forecast period.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market value of the scleral lenses was approximately 1.4% of the overall ~US$ 11.8 billion global contact lens market in 2021.
The sales of scleral lens products expanded at a CAGR of 3.0% from 2012 to 2021.
Over the projection period, it is anticipated that there will be a strong demand for scleral lenses because of the rising incidence of eye illnesses and difficulties. The market for scleral lenses is anticipated to develop as a result of the rising demand for eye movement analysis. The market is also anticipated to develop because of the increasing older population, a rise in the number of people seeking treatment, and changes in lifestyle.
The market for scleral lenses is anticipated to expand as a result of rising demand for non-surgical products for vision care and treatment. One of the major trends in the scleral lenses industry is the rise in customized scleral lens production. The market is anticipated to rise as scleral lenses are increasingly prescribed to treat corneal irregularities and ocular surface diseases.
As per an article published in 2017 by the contact lens spectrum, the SCOPE (Scleral Lenses in Current Ophthalmic Practice Evaluation) study group, in n=673, it was observed that the most frequent reason for using scleral lenses was reported to be corneal irregularity, 74%, followed by ocular surface illness, 16%, and refractive error, 10%.
Thus, owing to the aforementioned factors, the global market for scleral lenses is expected to grow at a CAGR of 6.3% during the forecast period from 2022 to 2032.
Considering the growing awareness in developing countries, the market is expected to have a positive outlook. The adoption rate is increasing with new products entering the emerging market. This growth is attributed to the developing nations' increasing collaboration and effort of the manufacturers.
For instance, The LV Prasad Eye Institute (LVPEI) and Boston Foundation collaborated in 2017 to improve access to specialized lenses for patients in developing geographies. There is now Boston Sight SCLERAL & PROSE in India and they are starting to cater to patients in other countries of South and Middle-East Asia as well.
The market is having an opportunistic outlook as the patient currently looks for advanced products that would ease their day-to-day activities along with providing comfort. This in turn benefits the manufacturers who are involved in providing new and customized products as per the need of the patients.
Thus, this can be considered an opportunistic factor for the growth and wider adoption of scleral lenses.
Principal Consultant
The major factor restraining the demand for scleral lenses is the high cost of the scleral lenses. These lenses are four to five times more expensive compared to other soft contact lenses or other standard contact lenses. The cost of the customized scleral lenses can be more than $4000 as well.
This in turn significantly decreases the adoption of scleral lenses for low and middle-income group patients. There are also minimal options for reimbursement of scleral lenses and most insurance companies do not directly cover the full cost of these lenses and thus can be a restraining factor in this aspect. Thus, it is a major growth concern, especially in some developing countries.
Other than this, certain side effects of the use of scleral lenses also have a negative impact on market growth. As per a retrospective study of keratoconus subjects examined between 2013 and 2018, conducted by the Southern College of Optometry, the complications of scleral lenses included 90.8% poor lens wetting, 84.8% lens fogging, 53% blurred vision, 34.8% ocular redness, 24.4% ocular dryness and 20.7% ocular pain and discomfort.
Thus, these abovementioned factors restrain the developmental growth of the scleral lenses market.
The USA dominates the North American region with total market revenue of about US$ 69.09 million, and a similar trend is expected over the forecast period.
Due to the strong demand for scleral lenses as a treatment choice for various eye disorders in the USA, the country dominates the North American market for scleral lenses. The increasing number of eye disorders in The USA is adding to the wider adoption of scleral lenses. For instance, as per the Cornea Research Foundation of America, approximately 50 to 200 of every 100,000 people are afflicted with keratoconus.
Hence, the sales of scleral lenses in the USA are quite high and are anticipated to grow moving forward.
In 2021, Germany held a market share of about 44.7% in the Europe market.
Technical developments and growth in the usage of non-surgical eye care products are driving the industry forward. The development of a protective aqueous vault over the cornea, computer-assisted lens designs, computerized measurements of the topography of the ocular surface, and high-tech lens material qualities are a few examples of technical developments. Because of these technological developments, scleral lenses are now more widely used in Germany.
Thus, considering this factor, the market for scleral lenses in Germany is quite lucrative.
India held approximately 59.8% market share in South Asia in 2021.
In terms of scleral lenses, India is expected to see faster growth rates because of the advancements in medical technology, government support for the treatment of eye problems, and a large patient base. The increasing population in India and the increasing number of eye diseases will eventually increase the adoption of scleral lenses in the region.
Thus, it has eventually boosted the availability of scleral lens products in India and is expected to show optimum growth in the forecast period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Mini scleral lenses are expected to present high growth at a CAGR of 4.9% by the end of the forecast period, with a contributing value of nearly US$ 79.2 million in the global market in 2021. Mini-scleral lenses are firm lenses with a large diameter that are used to restore vision when the cornea is deformed due to disease, scarring, or following a corneal graft operation. It is safe as well as well tolerated by many patients. The use of these lenses improves the quality of life. This is why the usage of mini scleral lenses is highest in the scleral lenses market.
Corneal irregularity is the most common indication and accounted for the largest revenue share globally valued at US$ 82.2 million in 2021. Corneal irregularities such as keratoconus and pellucid marginal degeneration are quite common. These instances are mostly known to be caused by genetic and environmental factors as well as collagen abnormalities. Corneal irregularity causes symptoms like distorted and blurry vision, sudden onset vision, or eye pain. The market is growing with the increase in cases of corneal irregularity.
The leading companies engage in a variety of product launches, expansions, collaborations, mergers, and acquisitions to enhance their global presence and improve their business strategy.
The primary advertising tactics used by the major participants in the scleral lenses market are listed below:
Similarly, recent developments related to companies manufacturing scleral lenses, have been tracked by the team at Future Market Insights, which are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2032 |
| Historical Data Available for | 2012 to 2021 |
| Market Analysis | US$ million for Value, Units for Volume |
| Key Regions Covered | North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East & Africa |
| Key Countries Covered | The USA Canada, Mexico, Brazil, Argentina, The United Kingdom, Germany, Italy, France, Spain, Russia, BENELUX, China, Japan, South Korea, India, Indonesia, Malaysia, Thailand, Australia, New Zealand, GCC Countries, Turkey, South Africa, and North Africa |
| Key Market Segments Covered | Product, Indication, and Region |
| Key Companies Profiled |
|
| Pricing | Available upon Request |
The global market for scleral lenses is estimated to be worth US$ 175.5 million in 2022.
The scleral lenses market is expected to reach US$ 323.5 million by end of 2032 at a CAGR of 6.3%.
Growing awareness regarding scleral lenses, a rising number of eye disorders, and expanded distribution networks of manufacturing companies, are some of the key trends in this market.
North America dominated the global market accounting for the highest market share of 42.9% in 2021, while growing at a CAGR of close to 5.6%
The United Kingdom market contributes around US$ 14.9 million in 2021 in the Europe market.
India accounts for about 59.8% of the market share of the South Asian market in 2021.
The USA, Germany, The United Kingdom, India, and Australia are the top five countries, which are expected to drive demand in the global market.
From 2012 to 2021, the market for scleral lenses expanded at a CAGR of 3.0%.
Australia accounted for 78.0% market share of the Oceania market in 2021.
Germany held a market share of around 44.7% of the Europe market in 2021.
1. Executive Summary | Scleral Lenses Market 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Key Success Factors 4.1. Product Adoption / Usage Analysis 4.2. Product Features / USPs Analysis 4.3. Pipeline Assessment 4.4. PESTLE Analysis 4.5. Porter’s Analysis 4.6. Key Promotional Strategies, by Manufacturers 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Per-capita Healthcare Expenditure 5.1.3. Global Contact Lens Market Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Historic Growth of Top Companies 5.2.2. Cost of the Product 5.2.3. Impact of New Technology 5.2.4. Mergers and Acquisitions 5.2.5. Product Adoption Rate 5.2.6. Strategic Collaborations 5.3. Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID-19 Crisis - Impact Assessment 6.1. COVID-19 and Impact Analysis 6.1.1. By Product 6.1.2. By Indication 6.1.3. By Region 6.2. 2021 Market Scenario 7. Global Market Demand (in Volume (Units)) Analysis 2012 to 2021 and Forecast, 2022 to 2032 7.1. Historical Market Volume (Units) Analysis, 2012 to 2021 7.2. Current and Future Market Volume (Units) Projections, 2022 to 2032 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Market - Pricing Analysis 8.1. Regional Pricing Analysis By Product 8.2. Pricing Break-up 8.2.1. Manufacturer Level Pricing 8.2.2. Distributor Level Pricing 8.3. Global Average Pricing Analysis Benchmark 8.4. Pricing Assumptions 9. Global Market Demand (in Value or Size in US$ million) Analysis 2012 to 2021 and Forecast, 2022 to 2032 9.1. Historical Market Value (US$ million) Analysis, 2012 to 2021 9.2. Current and Future Market Value (US$ million) Projections, 2022 to 2032 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Market Analysis, By Product 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ million) and Volume (Units) Analysis By Product, 2012 to 2021 10.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast By Product, 2022 to 2032 10.3.1. Mini Scleral Lens 10.3.2. Semi Scleral Lens 10.3.3. Large Scleral 10.4. Market Attractiveness Analysis By Product 11. Global Market Analysis, By Indication 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ million) Analysis by Indication, 2012 to 2021 11.3. Current and Future Market Size (US$ million) Analysis and Forecast by Indication, 2022 to 2032 11.3.1. Corneal Irregularity 11.3.2. Surface Ocular Disease 11.3.3. Refractive Error 11.3.4. Others 11.4. Market Attractiveness Analysis by Indication 12. Global Market Analysis, By Region 12.1. Introduction 12.2. Historical Market Size (US$ million) and Volume (Units) Analysis by Region, 2012 to 2021 12.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Region, 2022 to 2032 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. East Asia 12.3.5. South Asia 12.3.6. Oceania 12.3.7. Middle East and Africa (MEA) 12.4. Market Attractiveness Analysis by Region 13. North America Market Analysis 13.1. Introduction 13.2. Historical Market Size (US$ million) and Volume (Units) Analysis by Market Taxonomy, 2012 to 2021 13.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2022 to 2032 13.3.1. By Country 13.3.1.1. The USA 13.3.1.2. Canada 13.3.2. By Product 13.3.3. By Indication 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Product 13.4.3. By Indication 13.5. Country-Level Analysis & Forecast 13.5.1. The USA Market Analysis 13.5.1.1. . Introduction 13.5.1.2. Key Market Trends 13.5.1.3. Market Analysis and Forecast by Market Taxonomy 13.5.1.3.1. By Product 13.5.1.3.2. By Indication 13.5.2. Canada Market Analysis 13.5.2.1. Introduction 13.5.2.2. Market Analysis and Forecast by Market Taxonomy 13.5.2.2.1. By Product 13.5.2.2.2. By Indication 13.6. Key Market Participants - Intensity Mapping 13.7. Drivers and Restraints - Impact Analysis 14. Latin America Market Analysis 14.1. Introduction 14.2. Historical Market Size (US$ million) and Volume (Units) Analysis by Market Taxonomy, 2012 to 2021 14.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2022 to 2032 14.3.1. By Country 14.3.1.1. Mexico 14.3.1.2. Brazil 14.3.1.3. Argentina 14.3.1.4. Rest of Latin America 14.3.2. By Product 14.3.3. By Indication 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product 14.4.3. By Indication 14.5. Country-Level Analysis & Forecast 14.5.1. Mexico Market Analysis 14.5.1.1. Introduction 14.5.1.2. Market Analysis and Forecast by Market Taxonomy 14.5.1.2.1. By Product 14.5.1.2.2. By Indication 14.5.2. Brazil Market Analysis 14.5.2.1. Introduction 14.5.2.2. Market Analysis and Forecast by Market Taxonomy 14.5.2.2.1. By Product 14.5.2.2.2. By Indication 14.5.3. Argentina Market Analysis 14.5.3.1. Introduction 14.5.3.2. Market Analysis and Forecast by Market Taxonomy 14.5.3.2.1. By Product 14.5.3.2.2. By Indication 14.6. Key Market Participants - Intensity Mapping 14.7. Drivers and Restraints - Impact Analysis 15. Europe Market Analysis 15.1. Introduction 15.2. Historical Market Size (US$ million) and Volume (Units) Analysis by Market Taxonomy, 2012 to 2021 15.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2022 to 2032 15.3.1. By Country 15.3.1.1. The United Kingdom 15.3.1.2. Germany 15.3.1.3. Italy 15.3.1.4. France 15.3.1.5. Spain 15.3.1.6. Russia 15.3.1.7. BENELUX 15.3.1.8. Rest of Europe 15.3.2. By Product 15.3.3. By Indication 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product 15.4.3. By Indication 15.5. Country-Level Analysis & Forecast 15.5.1. The United Kingdom Market Analysis 15.5.1.1. Introduction 15.5.1.2. Market Analysis and Forecast by Market Taxonomy 15.5.1.2.1. By Product 15.5.1.2.2. By Indication 15.5.2. Germany Market Analysis 15.5.2.1. Introduction 15.5.2.2. Market Analysis and Forecast by Market Taxonomy 15.5.2.2.1. By Product 15.5.2.2.2. By Indication 15.5.3. Italy Market Analysis 15.5.3.1. Introduction 15.5.3.2. Market Analysis and Forecast by Market Taxonomy 15.5.3.2.1. By Product 15.5.3.2.2. By Indication 15.5.4. France Market Analysis 15.5.4.1. Introduction 15.5.4.2. Market Analysis and Forecast by Market Taxonomy 15.5.4.2.1. By Product 15.5.4.2.2. By Indication 15.5.5. Spain Market Analysis 15.5.5.1. Introduction 15.5.5.2. Market Analysis and Forecast by Market Taxonomy 15.5.5.2.1. By Product 15.5.5.2.2. By Indication 15.5.6. Russia Market Analysis 15.5.6.1. Introduction 15.5.6.2. Market Analysis and Forecast by Market Taxonomy 15.5.6.2.1. By Product 15.5.6.2.2. By Indication 15.5.7. BENELUX Market Analysis 15.5.7.1. Introduction 15.5.7.2. Market Analysis and Forecast by Market Taxonomy 15.5.7.2.1. By Product 15.5.7.2.2. By Indication 15.6. Key Market Participants - Intensity Mapping 15.7. Drivers and Restraints - Impact Analysis 16. East Asia Market Analysis 16.1. Introduction 16.2. Historical Market Size (US$ million) and Volume (Units) Analysis by Market Taxonomy, 2012 to 2021 16.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2022 to 2032 16.3.1. By Country 16.3.1.1. China 16.3.1.2. Japan 16.3.1.3. South Korea 16.3.2. By Product 16.3.3. By Indication 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.4.3. By Indication 16.5. Country-Level Analysis & Forecast 16.5.1. China Market Analysis 16.5.1.1. Introduction 16.5.1.2. Market Analysis and Forecast by Market Taxonomy 16.5.1.2.1. By Product 16.5.1.2.2. By Indication 16.5.2. Japan Market Analysis 16.5.2.1. Introduction 16.5.2.2. Market Analysis and Forecast by Market Taxonomy 16.5.2.2.1. By Product 16.5.2.2.2. By Indication 16.5.3. South Korea Market Analysis 16.5.3.1. Introduction 16.5.3.2. Market Analysis and Forecast by Market Taxonomy 16.5.3.2.1. By Product 16.5.3.2.2. By Indication 16.6. Key Market Participants - Intensity Mapping 16.7. Drivers and Restraints - Impact Analysis 17. South Asia Market Analysis 17.1. Introduction 17.2. Historical Market Size (US$ million) and Volume (Units) Analysis by Market Taxonomy, 2012 to 2021 17.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2022 to 2032 17.3.1. By Country 17.3.1.1. India 17.3.1.2. Indonesia 17.3.1.3. Malaysia 17.3.1.4. Thailand 17.3.1.5. Rest of South Asia 17.3.2. By Product 17.3.3. By Indication 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.4.3. By Indication 17.5. Country-Level Analysis & Forecast 17.5.1. India Market Analysis 17.5.1.1. Introduction 17.5.1.2. Market Analysis and Forecast by Market Taxonomy 17.5.1.2.1. By Product 17.5.1.2.2. By Indication 17.5.2. Indonesia Market Analysis 17.5.2.1. Introduction 17.5.2.2. Market Analysis and Forecast by Market Taxonomy 17.5.2.2.1. By Product 17.5.2.2.2. By Indication 17.5.3. Malaysia Market Analysis 17.5.3.1. Introduction 17.5.3.2. Market Analysis and Forecast by Market Taxonomy 17.5.3.2.1. By Product 17.5.3.2.2. By Indication 17.5.4. Thailand Market Analysis 17.5.4.1. Introduction 17.5.4.2. Market Analysis and Forecast by Market Taxonomy 17.5.4.2.1. By Product 17.5.4.2.2. By Indication 17.6. Key Market Participants - Intensity Mapping 17.7. Drivers and Restraints - Impact Analysis 18. Oceania Market Analysis 18.1. Introduction 18.2. Historical Market Size (US$ million) and Volume (Units) Analysis by Market Taxonomy, 2012 to 2021 18.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2022 to 2032 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Product 18.3.3. By Indication 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Product 18.4.3. By Indication 18.5. Country-Level Analysis & Forecast 18.5.1. Australia Market Analysis 18.5.1.1. Introduction 18.5.1.2. Market Analysis and Forecast by Market Taxonomy 18.5.1.2.1. By Product 18.5.1.2.2. By Indication 18.5.2. New Zealand Market Analysis 18.5.2.1. Introduction 18.5.2.2. Market Analysis and Forecast by Market Taxonomy 18.5.2.2.1. By Product 18.5.2.2.2. By Indication 18.6. Key Market Participants - Intensity Mapping 18.7. Drivers and Restraints - Impact Analysis 19. Middle East and Africa Market Analysis 19.1. Introduction 19.2. Historical Market Size (US$ million) and Volume (Units) Analysis by Market Taxonomy, 2012 to 2021 19.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2022 to 2032 19.3.1. By Country 19.3.1.1. GCC Countries 19.3.1.2. Turkey 19.3.1.3. South Africa 19.3.1.4. North Africa 19.3.1.5. Rest of Middle East and Africa 19.3.2. By Product 19.3.3. By Indication 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Product 19.4.3. By Indication 19.5. Country-Level Analysis & Forecast 19.5.1. GCC Countries Market Analysis 19.5.1.1. Introduction 19.5.1.2. Market Analysis and Forecast by Market Taxonomy 19.5.1.2.1. By Product 19.5.1.2.2. By Indication 19.5.2. Turkey Market Analysis 19.5.2.1. Introduction 19.5.2.2. Market Analysis and Forecast by Market Taxonomy 19.5.2.2.1. By Product 19.5.2.2.2. By Indication 19.5.3. South Africa Market Analysis 19.5.3.1. Introduction 19.5.3.2. Market Analysis and Forecast by Market Taxonomy 19.5.3.2.1. By Product 19.5.3.2.2. By Indication 19.5.4. North Africa Market Analysis 19.5.4.1. Introduction 19.5.4.2. Market Analysis and Forecast by Market Taxonomy 19.5.4.2.1. By Product 19.5.4.2.2. By Indication 19.6. Key Market Participants - Intensity Mapping 19.7. Drivers and Restraints - Impact Analysis 20. Market Structure Analysis 20.1. Market Analysis by Tier of Companies 20.2. Market Share Analysis of Top Players 20.3. Market Concentration 20.4. Market Presence Analysis 21. Competition Analysis 21.1. Competition Dashboard 21.2. Competition Deep Dive 21.2.1. Cooper Vision 21.2.1.1. Overview 21.2.1.2. Product Portfolio 21.2.1.3. Sales Footprint 21.2.1.4. Key Financials 21.2.1.5. SWOT Analysis 21.2.1.6. Strategy Overview 21.2.1.6.1. Marketing Strategy 21.2.1.6.2. Product Strategy 21.2.1.6.3. Channel Strategy 21.2.2. (VisionaryOptic) Euclid Systems 21.2.2.1. Overview 21.2.2.2. Product Portfolio 21.2.2.3. Sales Footprint 21.2.2.4. Key Financials 21.2.2.5. SWOT Analysis 21.2.2.6. Strategy Overview 21.2.2.6.1. Marketing Strategy 21.2.2.6.2. Product Strategy 21.2.2.6.3. Channel Strategy 21.2.3. Bausch & Lomb 21.2.3.1. Overview 21.2.3.2. Product Portfolio 21.2.3.3. Sales Footprint 21.2.3.4. Key Financials 21.2.3.5. SWOT Analysis 21.2.3.6. Strategy Overview 21.2.3.6.1. Marketing Strategy 21.2.3.6.2. Product Strategy 21.2.3.6.3. Channel Strategy 21.2.4. Art Optical Contact Lens, Inc. 21.2.4.1. Overview 21.2.4.2. Product Portfolio 21.2.4.3. Sales Footprint 21.2.4.4. Key Financials 21.2.4.5. SWOT Analysis 21.2.4.6. Strategy Overview 21.2.4.6.1. Marketing Strategy 21.2.4.6.2. Product Strategy 21.2.4.6.3. Channel Strategy 21.2.5. AccuLens 21.2.5.1. Overview 21.2.5.2. Product Portfolio 21.2.5.3. Sales Footprint 21.2.5.4. Key Financials 21.2.5.5. SWOT Analysis 21.2.5.6. Strategy Overview 21.2.5.6.1. Marketing Strategy 21.2.5.6.2. Product Strategy 21.2.5.6.3. Channel Strategy 21.2.6. Valley Contax Inc. 21.2.6.1. Overview 21.2.6.2. Product Portfolio 21.2.6.3. Sales Footprint 21.2.6.4. Key Financials 21.2.6.5. SWOT Analysis 21.2.6.6. Strategy Overview 21.2.6.6.1. Marketing Strategy 21.2.6.6.2. Product Strategy 21.2.6.6.3. Channel Strategy 21.2.7. ABB Optical Group 21.2.7.1. Overview 21.2.7.2. Product Portfolio 21.2.7.3. Sales Footprint 21.2.7.4. Key Financials 21.2.7.5. SWOT Analysis 21.2.7.6. Strategy Overview 21.2.7.6.1. Marketing Strategy 21.2.7.6.2. Product Strategy 21.2.7.6.3. Channel Strategy 21.2.8. EssilorLuxottica 21.2.8.1. Overview 21.2.8.2. Product Portfolio 21.2.8.3. Sales Footprint 21.2.8.4. Key Financials 21.2.8.5. SWOT Analysis 21.2.8.6. Strategy Overview 21.2.8.6.1. Marketing Strategy 21.2.8.6.2. Product Strategy 21.2.8.6.3. Channel Strategy 21.2.9. Optact International Ltd. 21.2.9.1. Overview 21.2.9.2. Product Portfolio 21.2.9.3. Sales Footprint 21.2.9.4. Key Financials 21.2.9.5. SWOT Analysis 21.2.9.6. Strategy Overview 21.2.9.6.1. Marketing Strategy 21.2.9.6.2. Product Strategy 21.2.9.6.3. Channel Strategy 21.2.10. Solotica, Smart Optics LLC 21.2.10.1. Overview 21.2.10.2. Product Portfolio 21.2.10.3. Sales Footprint 21.2.10.4. Key Financials 21.2.10.5. SWOT Analysis 21.2.10.6. Strategy Overview 21.2.10.6.1. Marketing Strategy 21.2.10.6.2. Product Strategy 21.2.10.6.3. Channel Strategy 21.2.11. OPTO CENTAR 21.2.11.1. Overview 21.2.11.2. Product Portfolio 21.2.11.3. Sales Footprint 21.2.11.4. Key Financials 21.2.11.5. SWOT Analysis 21.2.11.6. Strategy Overview 21.2.11.6.1. Marketing Strategy 21.2.11.6.2. Product Strategy 21.2.11.6.3. Channel Strategy 21.2.12. OKVision 21.2.12.1. Overview 21.2.12.2. Product Portfolio 21.2.12.3. Sales Footprint 21.2.12.4. Key Financials 21.2.12.5. SWOT Analysis 21.2.12.6. Strategy Overview 21.2.12.6.1. Marketing Strategy 21.2.12.6.2. Product Strategy 21.2.12.6.3. Channel Strategy 21.2.13. No7 Contact Lenses 21.2.13.1. Overview 21.2.13.2. Product Portfolio 21.2.13.3. Sales Footprint 21.2.13.4. Key Financials 21.2.13.5. SWOT Analysis 21.2.13.6. Strategy Overview 21.2.13.6.1. Marketing Strategy 21.2.13.6.2. Product Strategy 21.2.13.6.3. Channel Strategy 21.2.14. Multilens AB 21.2.14.1. Overview 21.2.14.2. Product Portfolio 21.2.14.3. Sales Footprint 21.2.14.4. Key Financials 21.2.14.5. SWOT Analysis 21.2.14.6. Strategy Overview 21.2.14.6.1. Marketing Strategy 21.2.14.6.2. Product Strategy 21.2.14.6.3. Channel Strategy 21.2.15. Laboratoire LCS 21.2.15.1. Overview 21.2.15.2. Product Portfolio 21.2.15.3. Sales Footprint 21.2.15.4. Key Financials 21.2.15.5. SWOT Analysis 21.2.15.6. Strategy Overview 21.2.15.6.1. Marketing Strategy 21.2.15.6.2. Product Strategy 21.2.15.6.3. Channel Strategy 21.2.16. HERZ submicron lathing s.r.l. 21.2.16.1. Overview 21.2.16.2. Product Portfolio 21.2.16.3. Sales Footprint 21.2.16.4. Key Financials 21.2.16.5. SWOT Analysis 21.2.16.6. Strategy Overview 21.2.16.6.1. Marketing Strategy 21.2.16.6.2. Product Strategy 21.2.16.6.3. Channel Strategy 21.2.17. Gelflex 21.2.17.1. Overview 21.2.17.2. Product Portfolio 21.2.17.3. Sales Footprint 21.2.17.4. Key Financials 21.2.17.5. SWOT Analysis 21.2.17.6. Strategy Overview 21.2.17.6.1. Marketing Strategy 21.2.17.6.2. Product Strategy 21.2.17.6.3. Channel Strategy 21.2.18. Firma Concor Ltd. 21.2.18.1. Overview 21.2.18.2. Product Portfolio 21.2.18.3. Sales Footprint 21.2.18.4. Key Financials 21.2.18.5. SWOT Analysis 21.2.18.6. Strategy Overview 21.2.18.6.1. Marketing Strategy 21.2.18.6.2. Product Strategy 21.2.18.6.3. Channel Strategy 21.2.19. Biolens Lab 21.2.19.1. Overview 21.2.19.2. Product Portfolio 21.2.19.3. Sales Footprint 21.2.19.4. Key Financials 21.2.19.5. SWOT Analysis 21.2.19.6. Strategy Overview 21.2.19.6.1. Marketing Strategy 21.2.19.6.2. Product Strategy 21.2.19.6.3. Channel Strategy 21.2.20. Appenzeller Kontaktlinsen AG 21.2.20.1. Overview 21.2.20.2. Product Portfolio 21.2.20.3. Sales Footprint 21.2.20.4. Key Financials 21.2.20.5. SWOT Analysis 21.2.20.6. Strategy Overview 21.2.20.6.1. Marketing Strategy 21.2.20.6.2. Product Strategy 21.2.20.6.3. Channel Strategy 21.2.21. Advanced Vision Technologies 21.2.21.1. Overview 21.2.21.2. Product Portfolio 21.2.21.3. Sales Footprint 21.2.21.4. Key Financials 21.2.21.5. SWOT Analysis 21.2.21.6. Strategy Overview 21.2.21.6.1. Marketing Strategy 21.2.21.6.2. Product Strategy 21.2.21.6.3. Channel Strategy 21.2.22. Metro Optics 21.2.22.1. Overview 21.2.22.2. Product Portfolio 21.2.22.3. Sales Footprint 21.2.22.4. Key Financials 21.2.22.5. SWOT Analysis 21.2.22.6. Strategy Overview 21.2.22.6.1. Marketing Strategy 21.2.22.6.2. Product Strategy 21.2.22.6.3. Channel Strategy 22. Assumptions and Acronyms Used 23. Research Methodology
Explore Healthcare Insights
View Reports
Scleral Lenses Market
